Cvs Health Corporation · NYSE:CVS
Cvs Health — 42nd Annual J.P. Morgan Healthcare Conference (January 2024)
9 slides from Cvs Health's conference presentation, Jan 8, 2024
Slide 1: J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Karen S. Lynch President and Chief Executive Officer Thomas F. Cowhey Chief Financial Officer January 8, 2024
Slide 2: Cautionary statement concerning forward-looking statements
Cautionary statement concerning forward-looking statements This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward- looking statements made by or on behalf of CVS Health Corporation (“CVS Health”). Certain stateme
Slide 3: Our vision: Building a world of health around every consumer
OUR VISION Building a world of health around every consumer ©2024 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 4: CVS Health, a trusted brand in health care
CVS Health, a trusted brand in health care $355B 120M+ Annual revenue1 Consumers we serve $17.4B 2.3B+ Adjusted operating income1 Pharmacy claims processed1,2 $13B+ 10M+ Operating cash flow3 Annual health services visits 300K+ 85% Purpose driven colleagues Of U.S. population lives within 10 miles of
Slide 5: Our businesses deliver strong value
Our businesses deliver strong value Health Care Health Pharmacy & Benefits Services Consumer Wellness $104.2B $182.7B $115.9B Annual revenue1 Annual revenue1 Annual revenue1 $5.70B $7.25B $5.81B Adjusted operating income1 Adjusted operating income1 Adjusted operating income1 35M+ 90M+ 120M Unique me
Slide 6: Advancing the future of health care
Advancing the future of health care Driving deeper Bringing excellence Innovating Increasing engagement and in hyper-local and evolving transparency in harnessing innovative convenience our PBM model retail pharmacy technologies ©2024 CVS Health and/or one of its affiliates. Confidential and proprie
Slide 7: 2023 & 2024 Guidance
In billions, Full year Full year except per share amounts and medical benefit ratios 2023 guidance 2024 guidance Upper-half of At least Total revenues $351.5 to $357.3 $366.0 Upper-half of At least Adjusted operating income 2023 & 2024 $17.21 to $17.57 $17.24 Guidance Adjusted earnings per share Upp
Slide 8: Long-term financial guidance
Long-term financial guidance • Adjusted EPS growth floor of 6% • Growth increasing over time • Opportunities to outperform, Segment Disciplined Clear opportunities including Medicare commitments investments and to outperform Advantage margin anchored to capital deployment improvement, are projected
Slide 9: Why CVS Health
Strong, sustainable growth, including accelerating growth from Health Care Delivery Powerful cash flow generation Why Balanced capital deployment with growing dividend CVS Health Commitment to sustainable business practices and employee development Accelerating our Adjusted EPS growth over time ©202
CVS Health — 42nd Annual J.P. Morgan Healthcare Conference (January 2024) on 6ix